Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane A2 in acute myocardial infarction.

P Walinsky, J B Smith, A M Lefer

    American Heart Journal
    |October 1, 1984
    PubMed
    Summary

    Thromboxane A2 is generated early in acute myocardial infarction (AMI). This study measured thromboxane B2 levels in dogs and patients, finding increased levels shortly after coronary occlusion or reperfusion in AMI.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

    Cardiovascular research·2001
    Same author

    PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.

    Cardiovascular research·2000
    Same author

    C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2000
    Same author

    C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.

    American journal of physiology. Heart and circulatory physiology·2000
    Same author

    Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion.

    The Journal of pharmacology and experimental therapeutics·2000
    Same author

    Plasma activation during splanchnic arterial occlusion shock.

    Shock (Augusta, Ga.)·2000

    Area of Science:

    • Cardiovascular Medicine
    • Biochemistry
    • Pathophysiology

    Background:

    • Thromboxane A2 (TXA2) is a potent vasoconstrictor implicated in cardiovascular events.
    • Understanding TXA2's role in acute myocardial infarction (AMI) is crucial for developing targeted therapies.

    Purpose of the Study:

    • To investigate the early presence and significance of thromboxane B2 (TXB2), the stable metabolite of TXA2, during acute myocardial infarction (AMI).

    Main Methods:

    • Animal study: Monitored TXB2 levels in dogs following left anterior descending artery (LAD) occlusion.
    • Patient study: Measured TXB2 concentrations in patients with AMI, including serial measurements before and after vessel recanalization.

    Main Results:

    • In dogs, TXB2 levels significantly increased at 1 and 5 minutes post-LAD occlusion, returning to baseline by 30-60 minutes.

    Related Experiment Videos

  • In AMI patients, TXB2 levels were elevated post-onset of chest pain and transiently increased after vessel reperfusion.
  • Higher TXB2 levels correlated with unsuccessful recanalization in two patients.

    • Conclusions:

    • TXA2 generation occurs in the early stages of AMI.
    • TXA2 may play a significant pathophysiological role in the development and progression of AMI.